NYSE$MYO
Myomo Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Achieved record revenue with a 128% increase year-over-year, driven by growth in the direct billing channel and unit sales.
Myomo reported record revenue of $4.4 million for Q3 2021, a 128% increase compared to Q3 2020. The growth was driven by a record direct billing channel revenue and a 100% increase in revenue units. Gross margin improved to 75%, and backlog increased to 177 units.
- Revenue reached a record $4.4 million, up 128% year-over-year.
- Direct billing channel revenue was a record, representing 85% of total revenue.
- Gross margin increased to 75%, a 1,900 basis point improvement.
- Backlog grew to a record 177 units as of September 30, 2021.
Headline financials
Revenue & EPS history
Myomo · Revenue · Quarterly
$4.38M
Forward guidance
Myomo anticipates strong year-over-year revenue growth for 2021 but faces short-term challenges in Q4 due to subcontractor labor shortages and claim denials, making revenue forecasting difficult.
Tailwinds
- Expects strong year-over-year revenue growth for 2021.
- Record number of units in backlog.
- Subcontractor capacity has returned to nearly normal.
- Focus on growing the pipeline.
- Focus on growing the backlog.
Headwinds
- Temporary labor shortage at a subcontractor constrained capacity and deliveries in early Q4.
- Difficulty in making up all delayed shipments by the end of the year.
- Delayed shipments and associated revenue may be realized in early 2022.
- Appealing a number of recent claim denials after pre-authorization and delivery to the patient.
- Difficult to forecast revenue for the fourth quarter.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
-5.0%
Avg return
Earnings day
-5.9%
Avg return
5 days after
-2.6%
Avg return
30 days after
23%
8 / 35 earnings
Positive
+40.8%
Q4 2024
Best reaction
-39.2%
Q4 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.5% | -10.3% | +50.1% | |
| Q4 2025 | -17.6% | -14.1% | -13.7% | |
| Q3 2025 | -3.3% | -11.0% | +17.8% | |
| Q1 2025 | -30.8% | -34.1% | -38.4% | |
| Q4 2024 | +40.8% | +24.5% | +2.9% | |
| Q3 2024 | +26.8% | +23.7% | +52.0% | |
| Q2 2024 | -10.8% | -1.5% | -7.6% | |
| Q1 2024 | -1.7% | +0.6% | -6.4% | |
| Q4 2023 | -13.3% | +3.3% | -17.1% | |
| Q3 2023 | +13.9% | +28.3% | +158.4% | |
| Q2 2023 | -0.3% | +9.4% | +65.6% | |
| Q1 2023 | -5.6% | -7.5% | -13.0% | |
| Q4 2022 | -3.1% | -6.8% | +1.4% | |
| Q3 2022 | -31.6% | -28.6% | -59.9% | |
| Q2 2022 | -6.1% | -4.4% | -0.6% | |
| Q1 2022 | -6.4% | -6.1% | -20.9% | |
| Q4 2021 | -39.2% | -41.6% | -46.5% | |
| Q3 2021 | -7.6% | -6.9% | -25.3% | |
| Q2 2021 | +15.4% | +22.5% | +32.7% | |
| Q1 2021 | -3.5% | -12.5% | -0.7% | |
| Q4 2020 | +1.4% | +20.0% | -3.2% | |
| Q3 2020 | +20.7% | +11.8% | +39.2% | |
| Q2 2020 | -1.8% | +0.8% | -5.6% | |
| Q1 2020 | -14.6% | -11.0% | -18.1% | |
| Q4 2019 | -20.5% | -30.1% | -16.7% | |
| Q3 2019 | -21.0% | -25.1% | -32.4% | |
| Q2 2019 | -0.8% | -3.5% | -3.7% | |
| Q1 2019 | -8.3% | -23.1% | -37.2% | |
| Q4 2018 | +6.6% | +4.9% | -2.5% | |
| Q3 2018 | -4.2% | -3.7% | -18.1% | |
| Q2 2018 | -5.5% | -8.3% | -9.6% | |
| Q1 2018 | -12.0% | -2.2% | -10.9% | |
| Q4 2017 | -3.6% | -19.3% | -38.2% | |
| Q3 2017 | -24.9% | -28.9% | -64.3% | |
| Q2 2017 | -5.7% | -14.1% | -0.3% | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro